Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

EPA:BIM - FR0013280286 - Common Stock

127.4 EUR
0 (0%)
Last: 8/22/2025, 7:00:00 PM
Fundamental Rating

6

Overall BIM gets a fundamental rating of 6 out of 10. We evaluated BIM against 57 industry peers in the Health Care Equipment & Supplies industry. BIM has an excellent financial health rating, but there are some minor concerns on its profitability. While showing a medium growth rate, BIM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BIM was profitable.
In the past year BIM had a positive cash flow from operations.
In the past 5 years BIM has always been profitable.
In the past 5 years BIM always reported a positive cash flow from operatings.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

BIM has a Return On Assets of 7.49%. This is in the better half of the industry: BIM outperforms 79.66% of its industry peers.
The Return On Equity of BIM (10.28%) is better than 71.19% of its industry peers.
BIM's Return On Invested Capital of 9.33% is fine compared to the rest of the industry. BIM outperforms 79.66% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BIM is in line with the industry average of 8.49%.
Industry RankSector Rank
ROA 7.49%
ROE 10.28%
ROIC 9.33%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 10.86%, BIM is in the better half of the industry, outperforming 72.88% of the companies in the same industry.
In the last couple of years the Profit Margin of BIM has remained more or less at the same level.
Looking at the Operating Margin, with a value of 14.79%, BIM is in the better half of the industry, outperforming 76.27% of the companies in the same industry.
In the last couple of years the Operating Margin of BIM has grown nicely.
BIM has a Gross Margin (55.66%) which is comparable to the rest of the industry.
BIM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.79%
PM (TTM) 10.86%
GM 55.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BIM is creating some value.
Compared to 1 year ago, BIM has about the same amount of shares outstanding.
The number of shares outstanding for BIM has been reduced compared to 5 years ago.
BIM has a better debt/assets ratio than last year.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 7.18 indicates that BIM is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.18, BIM belongs to the top of the industry, outperforming 94.92% of the companies in the same industry.
BIM has a debt to FCF ratio of 1.53. This is a very positive value and a sign of high solvency as it would only need 1.53 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.53, BIM belongs to the best of the industry, outperforming 88.14% of the companies in the same industry.
BIM has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.08, BIM belongs to the best of the industry, outperforming 86.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Altman-Z 7.18
ROIC/WACC1.21
WACC7.74%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

BIM has a Current Ratio of 2.20. This indicates that BIM is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.20, BIM is doing good in the industry, outperforming 69.49% of the companies in the same industry.
A Quick Ratio of 1.29 indicates that BIM should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.29, BIM is in the better half of the industry, outperforming 62.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.29
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.01% over the past year.
Measured over the past years, BIM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.91% on average per year.
BIM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.31%.
Measured over the past years, BIM shows a quite strong growth in Revenue. The Revenue has been growing by 8.27% on average per year.
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%

3.2 Future

The Earnings Per Share is expected to grow by 13.66% on average over the next years. This is quite good.
BIM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.62% yearly.
EPS Next Y18.23%
EPS Next 2Y15.22%
EPS Next 3Y14.58%
EPS Next 5Y13.66%
Revenue Next Year7.52%
Revenue Next 2Y7.56%
Revenue Next 3Y7.43%
Revenue Next 5Y6.62%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 33.01, which means the current valuation is very expensive for BIM.
The rest of the industry has a similar Price/Earnings ratio as BIM.
The average S&P500 Price/Earnings ratio is at 27.24. BIM is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 27.91 indicates a quite expensive valuation of BIM.
BIM's Price/Forward Earnings is on the same level as the industry average.
BIM is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.01
Fwd PE 27.91
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BIM is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as BIM.
Industry RankSector Rank
P/FCF 46.9
EV/EBITDA 16.77
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BIM does not grow enough to justify the current Price/Earnings ratio.
BIM has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BIM's earnings are expected to grow with 14.58% in the coming years.
PEG (NY)1.81
PEG (5Y)3.03
EPS Next 2Y15.22%
EPS Next 3Y14.58%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.71%, BIM is not a good candidate for dividend investing.
BIM's Dividend Yield is comparable with the industry average which is at 2.10.
With a Dividend Yield of 0.71, BIM pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.71%

5.2 History

On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BIM pays out 23.18% of its income as dividend. This is a sustainable payout ratio.
The dividend of BIM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP23.18%
EPS Next 2Y15.22%
EPS Next 3Y14.58%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (8/22/2025, 7:00:00 PM)

127.4

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-07 2025-03-07/bmo
Earnings (Next)09-04 2025-09-04
Inst Owners20.89%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap15.08B
Analysts75.29
Price Target127.5 (0.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.71%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP23.18%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.59%
EPS NY rev (3m)-1.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE 33.01
Fwd PE 27.91
P/S 3.79
P/FCF 46.9
P/OCF 22.6
P/B 3.59
P/tB 5.06
EV/EBITDA 16.77
EPS(TTM)3.86
EY3.03%
EPS(NY)4.56
Fwd EY3.58%
FCF(TTM)2.72
FCFY2.13%
OCF(TTM)5.64
OCFY4.43%
SpS33.63
BVpS35.53
TBVpS25.2
PEG (NY)1.81
PEG (5Y)3.03
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 10.28%
ROCE 12.7%
ROIC 9.33%
ROICexc 9.83%
ROICexgc 13.6%
OM 14.79%
PM (TTM) 10.86%
GM 55.66%
FCFM 8.08%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexcg growth 3Y-22.62%
ROICexcg growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Debt/EBITDA 0.39
Cap/Depr 106.34%
Cap/Sales 8.69%
Interest Coverage 250
Cash Conversion 73.01%
Profit Quality 74.39%
Current Ratio 2.2
Quick Ratio 1.29
Altman-Z 7.18
F-Score7
WACC7.74%
ROIC/WACC1.21
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
EPS Next Y18.23%
EPS Next 2Y15.22%
EPS Next 3Y14.58%
EPS Next 5Y13.66%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
Revenue Next Year7.52%
Revenue Next 2Y7.56%
Revenue Next 3Y7.43%
Revenue Next 5Y6.62%
EBIT growth 1Y34.12%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year61.98%
EBIT Next 3Y26.54%
EBIT Next 5Y19.38%
FCF growth 1Y200.19%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y49.82%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%